Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Retatrutide and Tirzepatide: Retatrutide and Tirzepatide are newer additions to the GLP-1 analogue family and are currently under investigation in clinical trials for obesity treatment
Our physicians evaluate your health history to ensure safe and effective treatment
Transient nausea was more frequent with GLP-1RAs and should be addressed through patient education and an incremental dosing approach
Keep in mind that although some of the alternatives may not have an indication for weight loss, people taking these medications may experience weight loss with an improvement in managing their diabetes
US$ 23.45
US$ 20.91
US$ 23.51
US$ 28.57
US$ 24.32
US$ 27.98
